Search - tctmd.com

Displaying 381 - 400 of 432

Sort: Relevancy | Date

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

Renal Denervation: Potential in Treating Heart Failure

Presenter: Erwin Blessing

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2013

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Presenter: Paul Sobotka

October 27, 2013

Presentation TCT 2013

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Renal Denervation for Congestive Heart Failure: Current Evidence and Ongoing Studies

Presenter: Justin Davies

October 27, 2013

Presentation TCT 2013

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Presenter: Felix Mahfoud

October 27, 2013

Presentation TCT 2013

Is Renal Denervation REALLY READY for Prime Time: A Critical Appraisal

Presenter: Darrel Francis

October 27, 2013

Presentation TCT 2013

How We Should Define "Responsiveness" to Renal Denervation Therapies

Presenter: Krishna Rocha-Singh

October 27, 2013

Presentation TCT 2013

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Presenter: Andrew Farb

October 27, 2013

Presentation TCT 2013

Ethanol Injection for Renal Denervation (Ablative Solutions)

Presenter: Tim Fischell

October 27, 2013

Presentation TCT 2013

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Presenter: Vivek Reddy

October 27, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Presenter: Marc Sapoval

October 27, 2013

Presentation TCT 2013

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Presenter: Jan Pietzsch

October 27, 2013

Presentation TCT 2013

Chemical Ablation for Renal Denervation (Northwind Technologies)

Presenter: Mark Wholey

October 27, 2013

Advertisement

Renal Denervation: Ready for Primetime?

Renal Denervation: Potential in Treating Heart Failure

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Preliminary Data Show Potential of Renal Denervation in Several Settings

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

The Spectrum of Current and Future Renal Denervation Clinical Trials

Strategies for Measuring Technical Success to Facilitate Ideal Patient Selection in Renal Denervation

Renal Denervation for Glycemic Control and Obstructive Sleep Apnea: An Update

Renal Denervation for Congestive Heart Failure: Current Evidence and Ongoing Studies

Moving Away From Surrogate Measures: Rationale and Design for a Clinical Outcomes Trial of Renal Artery Denervation (EnligHTNment)

Is Renal Denervation REALLY READY for Prime Time: A Critical Appraisal

How We Should Define "Responsiveness" to Renal Denervation Therapies

FDA Perspectives: Clinical Trial Regulatory Pathway for Renal Denervation Devices

Ethanol Injection for Renal Denervation (Ablative Solutions)

Electrophysiological Considerations for Renal Denervation: Implications for Arrhythmia Control

Device and Clinical Trial Update: Cordis Renal Denervation Approach

Cost-Effectiveness of Catheter-Based Renal Denervation in Severe Treatment Resistant Hypertension

Chemical Ablation for Renal Denervation (Northwind Technologies)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content